Great West Life Assurance CO Bei Gene, Ltd. Transaction History

Great West Life Assurance CO

$53.1 Billion
Q2 2024

A detailed history of Great West Life Assurance CO transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Great West Life Assurance CO holds 17,018 shares of BGNE stock, worth $4.19 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

17,018

Previous 28,304 39.87%

Holding current value

$4.19 Million

Previous $4.42 Million 45.05%

% of portfolio

0.0%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$129.52 - $174.32 $1.46 Million - $1.97 Million	-11,286 Reduced 39.87%	17,018 $2.43 Million
Q1 2024 May 13, 2024	BUY	$141.8 - $181.47 $181,787 - $232,644	1,282 Added 4.74%	28,304 $4.42 Million
Q4 2023 Feb 13, 2024	SELL	$158.67 - $201.58 $47.2 Million - $60 Million	-297,694 Reduced 91.68%	27,022 $4.84 Million
Q3 2023 Nov 14, 2023	BUY	$179.87 - $225.13 $49.1 Million - $61.5 Million	273,087 Added 528.94%	324,716 $8.33 Million
Q2 2023 Aug 10, 2023	SELL	$178.3 - $266.78 $245,519 - $367,356	-1,377 Reduced 2.6%	51,629 $9.23 Million
Q1 2023 May 12, 2023	SELL	$215.53 - $274.5 $6.16 Million - $7.85 Million	-28,600 Reduced 35.05%	53,006 $11.4 Million
Q4 2022 Feb 10, 2023	BUY	$125.51 - $229.3 $1.48 Million - $2.71 Million	11,800 Added 16.9%	81,606 $18 Million
Q3 2022 Nov 01, 2022	BUY	$131.8 - $202.24 $9.2 Million - $14.1 Million	69,806 New	69,806 $9.41 Million
Q2 2022 Aug 09, 2022	SELL	$121.11 - $216.05 $133,221 - $237,655	-1,100 Reduced 1.61%	67,106 $10.9 Million
Q1 2022 May 12, 2022	BUY	$146.52 - $269.56 $849,816 - $1.56 Million	5,800 Added 9.29%	68,206 $13.4 Million
Q4 2021 Feb 14, 2022	SELL	$248.56 - $389.34 $769,044 - $1.2 Million	-3,094 Reduced 4.72%	62,406 $16.8 Million
Q3 2021 Nov 15, 2021	BUY	$249.6 - $403.14 $1.8 Million - $2.9 Million	7,200 Added 12.35%	65,500 $23.9 Million
Q2 2021 Aug 11, 2021	BUY	$292.75 - $367.01 $2.11 Million - $2.64 Million	7,200 Added 14.09%	58,300 $20 Million
Q1 2021 May 17, 2021	BUY	$260.64 - $382.12 $1.09 Million - $1.6 Million	4,200 Added 8.96%	51,100 $17.7 Million
Q4 2020 Feb 16, 2021	BUY	$221.31 - $316.61 $5.98 Million - $8.55 Million	27,000 Added 135.68%	46,900 $12.1 Million
Q3 2020 Nov 13, 2020	BUY	$189.18 - $286.44 $227,016 - $343,728	1,200 Added 6.42%	19,900 $5.7 Million
Q2 2020 Aug 17, 2020	SELL	$123.9 - $195.41 $148,680 - $234,492	-1,200 Reduced 6.03%	18,700 $3.51 Million
Q1 2020 May 14, 2020	BUY	$121.84 - $173.19 $12,184 - $17,319	100 Added 0.51%	19,900 $2.47 Million
Q4 2019 Feb 11, 2020	SELL	$115.78 - $208.34 $312,606 - $562,518	-2,700 Reduced 12.0%	19,800 $3.28 Million
Q3 2019 Oct 25, 2019	BUY	$120.61 - $148.29 $253,281 - $311,409	2,100 Added 10.29%	22,500 $2.76 Million
Q2 2019 Jul 31, 2019	BUY	$113.99 - $146.86 $450,146 - $579,950	3,949 Added 24.0%	20,400 $0
Q1 2019 May 08, 2019	BUY	$122.82 - $151.83 $921,150 - $1.14 Million	7,500 Added 83.79%	16,451 $2.17 Million
Q4 2018 Feb 12, 2019	BUY	$107.01 - $175.15 $957,846 - $1.57 Million	8,951 New	8,951 $1.21 Million

Others Institutions Holding BGNE

# of Institutions

213

Shares Held

45.1M

Call Options Held

106K

Put Options Held

93.1K

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $25.5B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.

Account

Great West Life Assurance CO Bei Gene, Ltd. Transaction History